Variation in responses to incretin therapy: Modifiable and non-modifiable factors. (2023)

First Author: Austin GO
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fmolb.2023.1170181

PubMed Identifier: 37091864

Publication URI: http://europepmc.org/abstract/MED/37091864

Type: Journal Article/Review

Volume: 10

Parent Publication: Frontiers in molecular biosciences

ISSN: 2296-889X